Julie Rogers

Cooley advised Arboretum Ventures, a healthcare venture capital firm, on the closing of its $268 million sixth fund.

Cooley advised venture capital firm Upfront Ventures on its fundraise of more than $650 million to be deployed across three unique funds focused on various stages of the startup life cycle – the firm’s seventh early-stage fund, Upfront VII, which closed with $280 million in capital commitments; its third growth-stage fund, Upfront Growth III, with $200 million; and its Continuation Fund, with more than $175 million. Lawyers John Dado and Will Newsom led the Cooley team advising Upfront Ventures. 

Cooley advised 5AM Ventures, a venture capital firm focused on building next-generation life sciences companies, on the close of 5AM Ventures VII, a $450 million early-stage venture capital fund, and 5AM Opportunities II, a $300 million later-stage fund, for a total of $750 million in committed capital. Partners Nicole Peppe and Jimmy Matteucci led the Cooley team advising 5AM Ventures.

Cooley is advising M13, an early-stage consumer technology venture capital firm, on its recently announced third flagship fund. Lawyers John Dado, Luke Bagley, Paul Roberts, Mandy Kondo and Rand Singleton are leading the Cooley team advising M13.

Cooley advised Calibrate Ventures, a venture capital firm investing in early-revenue automation and artificial intelligence technology companies, on the closing of its second fund at $97 million. Partner Jordan Silber led the Cooley team advising Calibrate Ventures.